$30,000 of NEOGEN CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to food safety testing; issues related to Mycotoxin Test Kit Design Specifications and Performance Criteria; issues related to the review of rodenticides; issues related to Highly Pathogenic Avian Influenza; and issues related to imports and exports"
You can find more data on corporate lobbying on Quiver Quantitative.
NEOG Insider Trading Activity
NEOG insiders have traded $NEOG stock on the open market 10 times in the past 6 months. Of those trades, 10 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $NEOG stock by insiders over the last 6 months:
- JAMES C BOREL has made 2 purchases buying 65,000 shares for an estimated $320,990 and 0 sales.
- JEFFREY D CAPELLO purchased 20,712 shares for an estimated $100,217
- AASHIMA GUPTA purchased 16,000 shares for an estimated $99,987
- AMY M ROCKLIN (Chief Legal Officer) purchased 12,500 shares for an estimated $62,375
- JOHN PATRICK MOYLAN (Chief Accounting Officer) purchased 10,000 shares for an estimated $50,700
- JAMES P TOBIN purchased 10,000 shares for an estimated $47,268
- RAFAEL A RODRIGUEZ purchased 7,474 shares for an estimated $34,305
- CATHERINE E WOTEKI purchased 5,770 shares for an estimated $29,830
- WILLIAM T BOEHM purchased 5,000 shares for an estimated $26,175
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
NEOG Hedge Fund Activity
We have seen 176 institutional investors add shares of NEOG stock to their portfolio, and 185 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SOUTHPOINT CAPITAL ADVISORS LP added 10,000,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $47,800,000
- BAILLIE GIFFORD & CO removed 9,158,876 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $43,779,427
- CONESTOGA CAPITAL ADVISORS, LLC removed 8,540,859 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $40,825,306
- NORGES BANK removed 8,400,177 shares (-48.1%) from their portfolio in Q2 2025, for an estimated $40,152,846
- CLARKSTON CAPITAL PARTNERS, LLC added 7,729,650 shares (+123.2%) to their portfolio in Q2 2025, for an estimated $36,947,727
- CHAMPLAIN INVESTMENT PARTNERS, LLC removed 6,830,310 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $32,648,881
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 6,105,371 shares (-72.2%) from their portfolio in Q2 2025, for an estimated $29,183,673
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NEOG Analyst Ratings
Wall Street analysts have issued reports on $NEOG in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Guggenheim issued a "Buy" rating on 06/30/2025
To track analyst ratings and price targets for NEOG, check out Quiver Quantitative's $NEOG forecast page.
NEOG Price Targets
Multiple analysts have issued price targets for $NEOG recently. We have seen 3 analysts offer price targets for $NEOG in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Robert Labick from CJS Securities set a target price of $10.0 on 09/29/2025
- Subbu Nambi from Guggenheim set a target price of $10.0 on 06/30/2025
- David Westenberg from Piper Sandler set a target price of $5.0 on 04/22/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
